Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
The diagnosis, treatment, and monitoring of the primary systemic vasculitides associated with circulating antineutrophil cytoplasm autoantibodies (ANCA) have formed the focus of a multicenter collaborative study. Consensus has been reached on criteria for classification, clinical subgroupings by ext...
Hlavní autoři: | Jayne, DR, Rasmussen, N |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
1997
|
Podobné jednotky
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Autor: Mukhtyar, C, a další
Vydáno: (2006) -
Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
Autor: Rohini Handa
Vydáno: (2018-01-01) -
Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
Autor: John Chuan Nguyen Tran, a další
Vydáno: (2022-12-01) -
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Autor: Flossmann, O, a další
Vydáno: (2006) -
Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis
Autor: Brendan L. Thoms, a další
Vydáno: (2021-07-01)